Table 6.
Group* | Estimate | Standard Error | df | T | p-value |
---|---|---|---|---|---|
HIV− AA | −0.3597 | 0.2852 | 7646 | −1.26 | 0.2073 |
HIV+ AA | 0.00412 | 0.2029 | 7665 | 0.02 | 0.9838 |
HIV− AG/GG | 0.1364 | 0.09435 | 7714 | 1.45 | 0.1482 |
HIV+ AG/GG | −0.07033 | 0.07500 | 8141 | −0.94 | 0.3484 |
| |||||
Post Hoc Comparisons** | |||||
| |||||
HIV− AA vs. HIV− AG/GG | −0.4961 | 0.2774 | 7649 | −1.79 | 0.0738 |
HIV− AG/GG vs. HIV+ AG/GG | 0.2068 | 0.1122 | 7948 | 1.84 | 0.0654 |
All cases included regardless of stimulant use status
Only near-significant results are shown